home / stock / ssmxf / ssmxf news
2023-11-05 12:17:29 ET Summary The UST yield curve has steepened and this could provide an opportunity to buy US banking stocks on weakness in a no-recession scenario. Japan and Eurozone exporters can benefit from a global downturn due to easier central bank policies depreciating ...
Sysmex Corporation press release ( OTCPK:SSMXY ): Q1 GAAP EPS of ¥38.37. Revenue of ¥86.03B (+8.0% Y/Y). For further details see: Sysmex Corporation GAAP EPS of ¥38.37, revenue of ¥86.03B
Harding Loevner has been investing globally in high-quality, growing businesses based on disciplined industry research since 1989. Stock markets fell in the quarter, as the world watched in horror Russia’s invasion of Ukraine. While we are optimistic that China will maintai...
Harding Loevner has been investing globally in high-quality, growing businesses based on disciplined industry research since 1989. Stock markets fell in the quarter, as the world watched in horror Russia’s invasion of Ukraine. China-based WuXi Biologics illustrates the perf...
Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Total return for Harding Loevner International Equity Fund net of fees was 5.43% vs. MSCI All Country World ex-US ...
Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affiliated Managers Group. The Glob...
Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. The current low-quality rally offers an opportunity to look back on the lessons from the last time the markets coo...
Original post Editor's Note : The summary bullets for this article were chosen by Seeking Read more ...
Quick Take ICON plc ( ICLR ) has acquired MolecularMD for an undisclosed amount. MolecularMD [MMD] has developed a full service diagnostics service line to accelerate oncology (cancer) drug approval. With the deal for MMD, ICLR gains increased capabilities in the laboratory molecular d...
News, Short Squeeze, Breakout and More Instantly...